Literature DB >> 23423502

Prediabetes is associated with a high-risk colorectal adenoma.

Jae Myung Cha1, Joung Il Lee, Kwang Ro Joo, Hyun Phil Shin, Jung Won Jeun, Jun Uk Lim.   

Abstract

BACKGROUND: Type 2 diabetes mellitus is associated with an increased risk of colorectal neoplasia. However, association between prediabetes and colorectal adenoma has not been reported. AIMS: The aim of this study was to evaluate the relationship between prediabetes and the presence of colorectal adenomas.
METHODS: Consecutive prediabetic subjects who underwent screening colonoscopy were enrolled at Kyung Hee University Hospital in Gangdong, Seoul, Korea, between June 2006 and May 2012. Non-prediabetic subjects were separately pooled from the database of the Center for Health Promotion between January 2012 and May 2012. Prediabetes was defined according to the recommendations of the American Diabetes Association. The prevalence of colorectal adenomas and their characteristics were compared between prediabetic and non-prediabetic groups.
RESULTS: The prevalence of colorectal adenoma was higher in prediabetic subjects than in non-prediabetic subjects (39.6 vs. 30.6 %, respectively, p = 0.019). Prediabetic subjects had more multiple and high-risk adenomas than the control group in non-matched analysis (p = 0.000, respectively). In age-matched analysis, the prevalence of multiple and high-risk adenomas were significantly higher in a prediabetic group than those in a control group (44.4 vs. 28.4 %, p = 0.034; 51.9 vs. 34.6 %, p = 0.026, respectively). Furthermore, prediabetes (odds ratio = 2.198; 95 % confidence interval = 1.042-4.637; p = 0.039) was found to be an independent risk factor for a high-risk adenoma by multivariate analysis.
CONCLUSIONS: The prevalence of multiple and high-risk colorectal adenomas is significantly higher in the prediabetic subjects than those in the control group. Furthermore, prediabetes was found to be an independent risk factor for a high-risk colorectal adenoma.

Entities:  

Mesh:

Year:  2013        PMID: 23423502     DOI: 10.1007/s10620-013-2591-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Quality indicators for colonoscopy.

Authors:  Douglas K Rex; John L Petrini; Todd H Baron; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; Klaus Mergener; Bret T Petersen; Michael A Safdi; Douglas O Faigel; Irving M Pike
Journal:  Am J Gastroenterol       Date:  2006-04       Impact factor: 10.864

2.  Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line.

Authors:  L F Watkins; L R Lewis; A E Levine
Journal:  Int J Cancer       Date:  1990-02-15       Impact factor: 7.396

3.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  Type 2 diabetes mellitus and the risk of colorectal cancer.

Authors:  Yu-Xiao Yang; Sean Hennessy; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Clinical usefulness of glycosylated hemoglobin as a predictor of adenomatous polyps in the colorectum of middle-aged males.

Authors:  Beom Jin Kim; Young-Ho Kim; Dong Hyun Sinn; Ki Joo Kang; Jin Yong Kim; Dong Kyung Chang; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee
Journal:  Cancer Causes Control       Date:  2010-04-07       Impact factor: 2.506

7.  Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan).

Authors:  S Kono; S Honjo; I Todoroki; M Nishiwaki; H Hamada; H Nishikawa; H Koga; S Ogawa; K Nakagawa
Journal:  Cancer Causes Control       Date:  1998-08       Impact factor: 2.506

8.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

9.  Insulin therapy and colorectal adenoma risk among patients with Type 2 diabetes mellitus: a case-control study in Korea.

Authors:  Yong Woo Chung; Dong Soo Han; Kwang Hyuk Park; Chang Soo Eun; Kyo-Sang Yoo; Choong Kee Park
Journal:  Dis Colon Rectum       Date:  2008-01-25       Impact factor: 4.585

10.  The prediabetic period: review of clinical aspects.

Authors:  Sang Youl Rhee; Jeong-Taek Woo
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

View more
  3 in total

1.  Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study.

Authors:  Sander de Kort; Mariëlle We Bouwens; Matty P Weijenberg; Maryska Lg Janssen-Heijnen; Adriaan P de Bruïne; Robert Riedl; Ad Am Masclee; Silvia Sanduleanu
Journal:  United European Gastroenterol J       Date:  2016-08-09       Impact factor: 4.623

2.  Diabetes Mellitus and Site-specific Colorectal Cancer Risk in Korea: A Case-control Study.

Authors:  Hyeongtaek Woo; Jeeyoo Lee; Jeonghee Lee; Ji Won Park; Sungchan Park; Jeongseon Kim; Jae Hwan Oh; Aesun Shin
Journal:  J Prev Med Public Health       Date:  2016-01

3.  Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.

Authors:  Lili Deng; Xiaotong Zhao; Mingwei Chen; Hua Ji; Qunhui Zhang; Ruofei Chen; Yalei Wang
Journal:  BMC Endocr Disord       Date:  2020-05-11       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.